SHANDONG WEIGAO GROUP MEDICAL POLYMER COMPANY LIMITED

Cash flow Shandong Weigao Group Medical Polymer Company Limited

Equities

1066

CNE100000171

Medical Equipment, Supplies & Distribution

Market Closed - Hong Kong S.E. Other stock markets 03:08:09 2026-02-13 am EST			5-day change	1st Jan Change
5.200 ^HKD	-1.89%		-2.26%	+3.59%

Jan. 05	Shandong Weigao Group Finalizes Sale of Drug Packaging Arm to Affiliate	MT
Nov. 11	Weigao Group Medical Polymer Unit Forms JV Firm in Indonesia	MT

38cb2df418e46456e20af0125.GCR5Ew7BexlvXbglmrJhG7SFgQyBn2lrZmuiZ8GZfHE.bnw4TEDyIntbPvZU2OgKcsTg6VTFpj4HCjPhJfKrKz8vFhVqSqgkeEISyw

Published financial data: SHANDONG WEIGAO GROUP MEDICAL POLYMER COMPANY LIMITED

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Revenues	11.35B	13.15B	13.62B	13.23B	13.09B
Total Revenues	11.35B	13.15B	13.62B	13.23B	13.09B
Cost of Goods Sold, Total	4.91B	5.9B	6.52B	6.62B	6.55B
Gross Profit	6.44B	7.25B	7.1B	6.61B	6.54B
Selling General & Admin Expenses, Total	3.66B	3.77B	3.54B	3.83B	3.63B
Provision for Bad Debts	32.76M	17.29M	32.95M	4.55M	7.77M
R&D Expenses	411M	492M	547M	593M	625M
Other Operating Expenses, Total	4.1B	4.28B	4.12B	4.43B	4.26B
Operating Income	2.33B	2.97B	2.98B	2.18B	2.27B
Interest Expense, Total	-179M	-140M	-191M	-273M	-250M
Interest And Investment Income	135M	156M	186M	239M	233M
Net Interest Expenses	-44.06M	15.11M	-5.21M	-34.4M	-16.97M
Income (Loss) On Equity Invest.	9.17M	69.46M	75.1M	76.86M	74.76M
Currency Exchange Gains (Loss)	-56.4M	-68.1M	175M	-16.6M	56.44M
Other Non Operating Income (Expenses)	208M	88.56M	157M	139M	158M
EBT, Excl. Unusual Items	2.45B	3.07B	3.38B	2.35B	2.55B
Merger & Related Restructuring Charges	-	-	-	-	-
Gain (Loss) On Sale Of Investments	33.13M	-	101M	5.97M	262K
Gain (Loss) On Sale Of Assets	1.68M	-2.94M	109M	-1.55M	2.91M
Asset Writedown	-6.87M	-	-10.81M	-9.7M	-173K
Legal Settlements	-	-230M	-260M	28.55M	4.47M
Other Unusual Items	16.86M	-	-	-	-
EBT, Incl. Unusual Items	2.5B	2.84B	3.32B	2.37B	2.55B
Income Tax Expense	346M	415M	424M	308M	391M
Earnings From Continuing Operations	2.15B	2.43B	2.89B	2.06B	2.16B
Earnings Of Discontinued Operations	-	-	-	-	-
Net Income to Company	2.15B	2.43B	2.89B	2.06B	2.16B
Minority Interest	-120M	-182M	-170M	-59.7M	-96.05M
Net Income - (IS)	2.03B	2.24B	2.72B	2B	2.07B
Net Income to Common Incl Extra Items	2.03B	2.24B	2.72B	2B	2.07B
Net Income to Common Excl. Extra Items	2.03B	2.24B	2.72B	2B	2.07B
Per Share Items
Net EPS - Basic	0.45	0.5	0.6	0.44	0.46
Basic EPS - Continuing Operations	0.45	0.5	0.6	0.44	0.46
Basic Weighted Average Shares Outstanding	4.49B	4.5B	4.51B	4.51B	4.54B
Net EPS - Diluted	0.45	0.5	0.6	0.44	0.45
Diluted EPS - Continuing Operations	0.45	0.5	0.6	0.44	0.45
Diluted Weighted Average Shares Outstanding	4.49B	4.52B	4.53B	4.52B	4.55B
Normalized Basic EPS	0.31	0.39	0.43	0.31	0.33
Normalized Diluted EPS	0.31	0.39	0.43	0.31	0.33
Dividend Per Share	0.13	0.14	0.16	0.17	0.22
Payout Ratio	34.55	29.1	27.23	36.6	42.13
American Depositary Receipts Ratio (ADR)	4	4	4	4	4
Supplemental Items
EBITDA	3B	3.66B	3.74B	3.05B	3.2B
EBITA	2.58B	3.21B	3.23B	2.46B	2.56B
EBIT	2.33B	2.97B	2.98B	2.18B	2.27B
EBITDAR	3.02B	3.67B	3.75B	3.06B	3.21B
Effective Tax Rate - (Ratio)	13.85	14.61	12.79	12.98	15.31
Current Domestic Taxes	-	-	-	-	-
Total Current Taxes	395M	486M	468M	403M	498M
Deferred Domestic Taxes	-	-	-	-	-
Total Deferred Taxes	-35.92M	-79.93M	-42.56M	-82.5M	-121M
Normalized Net Income	1.41B	1.74B	1.94B	1.41B	1.5B
Interest Capitalized	-	-	-	-	-
Interest on Long-Term Debt	23.26M	43.14M	41.25M	40.71M	43.43M
Supplemental Operating Expense Items
Selling and Marketing Expenses	2.64B	2.66B	2.43B	2.58B	2.34B
General and Administrative Expenses	1.02B	1.11B	1.12B	1.25B	1.29B
Research And Development Expense From Footnotes	526M	607M	665M	731M	772M
Net Rental Expense, Total	11.04M	8.23M	7.3M	10.65M	11.08M
Imputed Operating Lease Interest Expense	3.21M	2.18M	2.59M	5.37M	5.29M
Imputed Operating Lease Depreciation	7.83M	6.05M	4.71M	5.28M	5.79M
Stock-Based Comp., Other (Total)	30.66M	76.49M	91.77M	55.46M	36.02M
Total Stock-Based Compensation	30.66M	76.49M	91.77M	55.46M	36.02M

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	5.51B	6.63B	6.86B	6.99B	7.78B
Short Term Investments	470M	420M	495M	344M	311M
Trading Asset Securities, Total	-	10M	-	371K	231M
Total Cash And Short Term Investments	5.98B	7.06B	7.36B	7.33B	8.32B
Accounts Receivable, Total	5.08B	5.19B	5.74B	5.96B	6.34B
Other Receivables	636M	514M	711M	770M	853M
Notes Receivable	233M	429M	628M	642M	314M
Total Receivables	5.94B	6.13B	7.07B	7.37B	7.51B
Inventory	1.5B	1.73B	2.32B	2.5B	2.53B
Other Current Assets, Total	693M	1.19B	1.34B	1.43B	1.09B
Total Current Assets	14.13B	16.11B	18.09B	18.63B	19.44B
Gross Property Plant And Equipment	7.87B	8.68B	9.8B	10.44B	11.04B
Accumulated Depreciation	-2.1B	-2.49B	-2.94B	-3.44B	-3.95B
Net Property Plant And Equipment	5.77B	6.2B	6.86B	7.01B	7.08B
Long-term Investments	1.33B	1.42B	1.85B	1.9B	1.99B
Goodwill	3.2B	3.35B	3.64B	3.73B	3.83B
Other Intangibles, Total	1.87B	1.68B	1.57B	1.34B	1.18B
Accounts Receivable Long-Term	84.97M	40.96M	23.04M	15.3M	12.97M
Loans Receivable Long-Term	213M	319M	184M	147M	413M
Deferred Tax Assets Long-Term	140M	156M	159M	207M	249M
Deferred Charges Long-Term	92.58M	117M	147M	170M	122M
Other Long-Term Assets, Total	526M	974M	667M	527M	434M
Total Assets	27.34B	30.37B	33.2B	33.67B	34.76B
Liabilities
Accounts Payable, Total	1.75B	1.67B	1.72B	1.77B	2.09B
Accrued Expenses, Total	1B	1.01B	1.03B	-	-
Short-term Borrowings	-	-	-	-	-
Current Portion of Long-Term Debt	298M	601M	961M	2.55B	1.2B
Current Portion of Leases	8.58M	22.99M	29.32M	26.59M	38.94M
Current Income Taxes Payable	126M	150M	179M	240M	179M
Unearned Revenue Current, Total	287M	320M	383M	432M	359M
Other Current Liabilities	1.03B	1.34B	1.63B	2.57B	2.21B
Total Current Liabilities	4.5B	5.11B	5.93B	7.58B	6.08B
Long-Term Debt	4B	3.46B	3.4B	1.5B	2.8B
Long-Term Leases	22.12M	57.86M	104M	101M	151M
Unearned Revenue Non Current	70.9M	88.07M	76.74M	69.71M	64.34M
Deferred Tax Liability Non Current	267M	223M	200M	166M	89.63M
Other Non Current Liabilities	96.2M	523M	37M	264M	232M
Total Liabilities	8.95B	9.46B	9.75B	9.68B	9.42B
Common Stock, Total	452M	457M	457M	457M	457M
Additional Paid In Capital	2.58B	2.74B	2.74B	2.74B	2.74B
Retained Earnings	13.63B	15.31B	17.49B	18.89B	20.12B
Comprehensive Income and Other	889M	756M	982M	360M	435M
Total Common Equity	17.55B	19.27B	21.67B	22.45B	23.75B
Minority Interest	845M	1.64B	1.78B	1.54B	1.59B
Total Equity	18.39B	20.91B	23.45B	23.99B	25.34B
Total Liabilities And Equity	27.34B	30.37B	33.2B	33.67B	34.76B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	4.52B	4.57B	4.57B	4.57B	4.57B
ECS Total Common Shares Outstanding	4.52B	4.57B	4.57B	4.57B	4.57B
Book Value / Share	3.88	4.22	4.74	4.91	5.2
Tangible Book Value	12.48B	14.24B	16.46B	17.38B	18.74B
Tangible Book Value Per Share	2.76	3.11	3.6	3.8	4.1
Total Debt	4.33B	4.14B	4.49B	4.17B	4.19B
Net Debt	-1.66B	-2.92B	-2.87B	-3.16B	-4.13B
Debt Equivalent Oper. Leases	88.31M	65.85M	58.38M	85.21M	88.62M
Minority Interest, Total (Incl. Fin. Div)	845M	1.64B	1.78B	1.54B	1.59B
Equity Method Investments, Total	1.22B	1.32B	1.73B	1.81B	1.92B
Account Code - Inventory Valuation	6	6	6	6	6
Inventories - Raw Materials, Total	284M	344M	660M	705M	664M
Inventories - Finished Goods, Total	1.22B	1.39B	1.66B	1.79B	1.86B
Land - (BS)	7.95M	7.77M	8.49M	8.63M	8.89M
Buildings, Total	3.27B	3.78B	3.84B	3.93B	4.02B
Machinery, Total	3.11B	3.84B	4.66B	5B	5.61B
Full Time Employees	10.43K	11.12K	12.12K	12.52K	12.72K
Accumulated Allowance for Doubtful Accounts (Supple)	243M	255M	293M	284M	291M

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	2.03B	2.24B	2.72B	2B	2.07B
Depreciation & Amortization - CF	446M	482M	552M	635M	684M
Amortization of Goodwill and Intangible Assets - (CF)	245M	241M	251M	276M	288M
Depreciation & Amortization, Total	691M	724M	803M	912M	972M
Amortization of Deferred Charges, Total - (CF)	-	-	-	-	-
(Gain) Loss From Sale Of Asset	-1.68M	2.94M	-60.91M	2.15M	-2.91M
(Gain) Loss on Sale of Investments - (CF)	51.23M	-3.32M	-168M	21.48M	-22.93M
Asset Writedown & Restructuring Costs	6.87M	-	10.81M	9.7M	173K
Provision for Credit Losses	35.24M	-	-	-	-
(Income) Loss On Equity Investments - (CF)	-9.17M	-69.46M	-75.1M	-76.86M	-74.76M
Stock-Based Compensation (CF)	30.66M	76.49M	91.77M	55.46M	36.02M
Provision and Write-off of Bad Debts	-	26.98M	33.33M	5.34M	8.81M
Net Cash From Discontinued Operations	-	-	-	-	-
Other Operating Activities, Total	126M	238M	-6.63M	183M	98.84M
Change in Trading Asset Securities	-42.25M	49.86M	-70.02M	177M	33.41M
Change In Accounts Receivable	-1.01B	-59.91M	-802M	-235M	-398M
Change In Inventories	-241M	-178M	-538M	-202M	-78.04M
Change In Accounts Payable	559M	-63.39M	430M	-175M	132M
Change in Unearned Revenues	193M	32.37M	63.8M	61.02M	-47.02M
Change in Other Net Operating Assets	274M	14.41M	-220M	58.42M	66.5M
Cash from Operations	2.7B	3.04B	2.21B	2.8B	2.79B
Capital Expenditure	-896M	-1.07B	-1.07B	-648M	-598M
Sale of Property, Plant, and Equipment	48.9M	38.39M	5.75M	6.74M	1.33M
Cash Acquisitions	465K	-10.29M	-	-43.22M	-
Divestitures	-	-	26.92M	593K	-
Sale (Purchase) of Real Estate properties	-8.72M	-	-	-	-
Sale (Purchase) of Intangible assets	-60.03M	-46.2M	-43.67M	-38.09M	-49.38M
Investment in Marketable and Equity Securities, Total	-153M	-34.48M	-216M	18.6M	-228M
Net (Increase) Decrease in Loans Originated / Sold - Investing	1.5B	3.19M	-	-7.47M	-
Other Investing Activities, Total	-4.67M	-359M	-1.27B	-678M	-230M
Cash from Investing	423M	-1.48B	-2.57B	-1.39B	-1.1B
Short Term Debt Issued, Total	-	-	-	-	-
Long-Term Debt Issued, Total	1.55B	519M	968M	393M	2.84B
Total Debt Issued	1.55B	519M	968M	393M	2.84B
Short Term Debt Repaid, Total	-147M	-	-	-	-
Long-Term Debt Repaid, Total	-2.46B	-732M	-907M	-802M	-2.99B
Total Debt Repaid	-2.61B	-732M	-907M	-802M	-2.99B
Issuance of Common Stock	259M	261M	-	-	-
Repurchase of Common Stock	-	-72.86M	-35.25M	-36.53M	-73.91M
Common Dividends Paid	-701M	-653M	-742M	-733M	-871M
Common & Preferred Stock Dividends Paid	-701M	-653M	-742M	-733M	-871M
Other Financing Activities, Total	-294M	140M	-305M	-979M	-502M
Cash from Financing	-1.79B	-538M	-1.02B	-2.16B	-1.6B
Foreign Exchange Rate Adjustments	-53.94M	-54.44M	96.16M	24.33M	55.8M
Net Change in Cash	1.27B	963M	-1.28B	-724M	145M
Supplemental Items
Cash Interest Paid	182M	127M	185M	258M	211M
Cash Income Tax Paid (Refund)	381M	475M	483M	344M	509M
Levered Free Cash Flow	1.59B	825M	307M	968M	1.64B
Unlevered Free Cash Flow	1.7B	913M	426M	1.14B	1.79B
Change In Net Working Capital	-479M	626M	1.22B	506M	-10.25M
Net Debt Issued / Repaid	-1.06B	-213M	60.55M	-410M	-150M

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	5.43	6.36	5.84	4.06	4.15
Return on Total Capital	6.45	7.69	7.01	4.85	4.93
Return On Equity %	12.16	12.2	13.01	8.67	8.77
Return on Common Equity	12.04	12.04	13.26	9.06	8.95
Margin Analysis
Gross Profit Margin %	56.73	55.14	52.14	49.97	49.94
SG&A Margin	32.24	28.69	26.02	28.97	27.73
EBITDA Margin %	26.48	27.85	27.48	23.06	24.42
EBITA Margin %	22.73	24.41	23.7	18.58	19.57
EBIT Margin %	20.58	22.58	21.86	16.49	17.37
Income From Continuing Operations Margin %	18.95	18.45	21.25	15.58	16.53
Net Income Margin %	17.89	17.07	20	15.13	15.79
Net Avail. For Common Margin %	17.89	17.07	20	15.13	15.79
Normalized Net Income Margin	12.44	13.23	14.26	10.63	11.43
Levered Free Cash Flow Margin	14.03	6.27	2.25	7.32	12.5
Unlevered Free Cash Flow Margin	15.01	6.94	3.13	8.61	13.69
Asset Turnover
Asset Turnover	0.42	0.45	0.43	0.39	0.38
Fixed Assets Turnover	2.03	2.19	2.08	1.91	1.86
Receivables Turnover (Average Receivables)	2.41	2.56	2.49	2.25	2.13
Inventory Turnover (Average Inventory)	3.57	3.58	3.18	2.75	2.61
Short Term Liquidity
Current Ratio	3.14	3.15	3.05	2.46	3.2
Quick Ratio	2.6	2.5	2.33	1.85	2.55
Operating Cash Flow to Current Liabilities	0.6	0.59	0.37	0.37	0.46
Days Sales Outstanding (Average Receivables)	151.9	142.77	146.42	162.14	171.98
Days Outstanding Inventory (Average Inventory)	102.51	102.01	114.71	132.88	140.33
Average Days Payable Outstanding	102.18	164.77	86.66	93.58	107.38
Cash Conversion Cycle (Average Days)	152.23	80	174.47	201.45	204.93
Long Term Solvency
Total Debt/Equity	23.53	19.79	19.16	17.38	16.55
Total Debt / Total Capital	19.05	16.52	16.08	14.8	14.2
LT Debt/Equity	21.86	16.8	14.93	6.65	11.65
Long-Term Debt / Total Capital	17.7	14.03	12.53	5.67	9.99
Total Liabilities / Total Assets	32.75	31.15	29.37	28.74	27.1
EBIT / Interest Expense	13.05	21.15	15.56	7.99	9.11
EBITDA / Interest Expense	16.91	26.31	19.75	11.33	13
(EBITDA - Capex) / Interest Expense	11.9	18.68	14.16	8.96	10.61
Total Debt / EBITDA	1.43	1.12	1.19	1.35	1.29
Net Debt / EBITDA	-0.55	-0.79	-0.76	-1.02	-1.27
Total Debt / (EBITDA - Capex)	2.03	1.58	1.66	1.71	1.58
Net Debt / (EBITDA - Capex)	-0.78	-1.11	-1.06	-1.29	-1.56
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	9.26	13.16	3.1	-3.77	-1.08
Gross Profit, 1 Yr. Growth %	-0.8	11.95	-3.21	-9.36	-1.14
EBITDA, 1 Yr. Growth %	3.56	18.48	0.92	-19.91	4.75
EBITA, 1 Yr. Growth %	1.28	20.71	-0.5	-25.38	4.23
EBIT, 1 Yr. Growth %	1.27	23.59	-0.85	-28.32	4.25
Earnings From Cont. Operations, 1 Yr. Growth %	11.7	9.95	17.73	-30.12	4.9
Net Income, 1 Yr. Growth %	9.74	7.57	19.66	-27.57	3.24
Normalized Net Income, 1 Yr. Growth %	5.71	19.56	10.17	-27.7	6.32
Diluted EPS Before Extra, 1 Yr. Growth %	9.76	8.01	19.39	-27.92	2.27
Accounts Receivable, 1 Yr. Growth %	16.89	1.62	10.48	2.87	6.35
Inventory, 1 Yr. Growth %	20.71	10.99	29.95	7.38	1.33
Net Property, Plant and Equip., 1 Yr. Growth %	6.42	6.86	9.57	2.15	1.1
Total Assets, 1 Yr. Growth %	3.76	8.62	8.56	0.8	3.24
Tangible Book Value, 1 Yr. Growth %	18.22	12.49	14.46	5.02	7.79
Common Equity, 1 Yr. Growth %	8.44	6.84	11.66	3.13	5.8
Cash From Operations, 1 Yr. Growth %	16.12	8.85	-28.25	21.95	-0.31
Capital Expenditures, 1 Yr. Growth %	-4.87	17.97	-4.5	-39.49	-7.65
Levered Free Cash Flow, 1 Yr. Growth %	-1.76K	-49.97	-61.76	176.75	68.95
Unlevered Free Cash Flow, 1 Yr. Growth %	1.01K	-48.17	-52.09	142.57	57.34
Dividend Per Share, 1 Yr. Growth %	8.33	9.23	16.2	1.64	28.44
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	13.49	12.54	8.25	0.08	-2.43
Gross Profit, 2 Yr. CAGR %	8.17	5.73	4.69	-5.07	-5.34
EBITDA, 2 Yr. CAGR %	12.67	12.36	10.04	-9.3	-8.4
EBITA, 2 Yr. CAGR %	13.02	12.29	10.16	-12.97	-11.81
EBIT, 2 Yr. CAGR %	13.75	13.5	11.32	-14.77	-13.55
Earnings From Cont. Operations, 2 Yr. CAGR %	19.07	12.27	14.5	-8.41	-14.38
Net Income, 2 Yr. CAGR %	17.4	10.16	14.24	-6.21	-13.53
Normalized Net Income, 2 Yr. CAGR %	11.37	14.13	15.51	-10.66	-12.32
Diluted EPS Before Extra, 2 Yr. CAGR %	16.94	10.08	14.34	-6.54	-14.14
Accounts Receivable, 2 Yr. CAGR %	13.97	9.29	6.01	7.15	4.6
Inventory, 2 Yr. CAGR %	15	17.98	21.72	18.34	4.31
Net Property, Plant and Equip., 2 Yr. CAGR %	13.63	6.91	8.75	5.81	1.62
Total Assets, 2 Yr. CAGR %	6.77	7.35	8.97	4.93	2.01
Tangible Book Value, 2 Yr. CAGR %	19.33	16.12	14.02	9.96	6.4
Common Equity, 2 Yr. CAGR %	9.95	9.12	9.62	7.55	4.46
Cash From Operations, 2 Yr. CAGR %	10.23	14.32	-10.88	-4.78	10.26
Capital Expenditures, 2 Yr. CAGR %	6.17	6.62	8.56	-23.96	-25.25
Levered Free Cash Flow, 2 Yr. CAGR %	84.87	193.45	-56.87	9.84	116.24
Unlevered Free Cash Flow, 2 Yr. CAGR %	62.7	144.37	-50.79	13.1	95.36
Dividend Per Share, 2 Yr. CAGR %	13.45	8.78	12.66	8.67	14.26
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	21.71	14.29	9.46	4.41	-0.31
Gross Profit, 3 Yr. CAGR %	17.27	9.66	3.05	0.68	-3.78
EBITDA, 3 Yr. CAGR %	19.89	15.67	8.86	-0.44	-4.84
EBITA, 3 Yr. CAGR %	23.12	16.72	8.23	-2.61	-7.58
EBIT, 3 Yr. CAGR %	19.33	18.07	8.9	-3.17	-8.85
Earnings From Cont. Operations, 3 Yr. CAGR %	18.23	16.96	14.55	-2.25	-4.17
Net Income, 3 Yr. CAGR %	5.5	15.08	13.76	-1.37	-3.16
Normalized Net Income, 3 Yr. CAGR %	15.89	15.19	13.28	-1.13	-5.33
Diluted EPS Before Extra, 3 Yr. CAGR %	17.13	14.72	13.62	-1.47	-3.69
Accounts Receivable, 3 Yr. CAGR %	12.54	9.89	9.72	5.31	6.88
Inventory, 3 Yr. CAGR %	23.14	15.11	22.94	16.88	12.37
Net Property, Plant and Equip., 3 Yr. CAGR %	13.82	11.51	8.15	6.51	4.22
Total Assets, 3 Yr. CAGR %	17.68	8.18	8	6.39	4.37
Tangible Book Value, 3 Yr. CAGR %	-1.57	17.55	15.94	11.16	9.23
Common Equity, 3 Yr. CAGR %	9.58	9.9	10.23	7.57	6.97
Cash From Operations, 3 Yr. CAGR %	28.67	11	-1.57	0.12	-3.31
Capital Expenditures, 3 Yr. CAGR %	-14.41	10.44	4.33	-10.64	-18.87
Levered Free Cash Flow, 3 Yr. CAGR %	16.01	21.01	47.39	-16.28	26.79
Unlevered Free Cash Flow, 3 Yr. CAGR %	19.26	12.37	40.77	-13.53	26.26
Dividend Per Share, 3 Yr. CAGR %	13.46	12.03	11.2	8.86	14.9
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	13.9	18.54	16.7	8.47	4.74
Gross Profit, 5 Yr. CAGR %	12.86	15.18	12.21	3.75	0.15
EBITDA, 5 Yr. CAGR %	13.42	20.22	16.51	5.21	1.95
EBITA, 5 Yr. CAGR %	14.9	23.62	18.49	4.01	0.12
EBIT, 5 Yr. CAGR %	12.69	21.84	16.73	3.87	-0.27
Earnings From Cont. Operations, 5 Yr. CAGR %	13.36	18.63	17.33	6.33	2.35
Net Income, 5 Yr. CAGR %	12.78	15.21	9.52	6.33	2.24
Normalized Net Income, 5 Yr. CAGR %	12.08	18.58	16.44	4.33	2.29
Diluted EPS Before Extra, 5 Yr. CAGR %	12.6	16.65	16.52	5.98	1.88
Accounts Receivable, 5 Yr. CAGR %	13.37	9.19	10	8.81	7.86
Inventory, 5 Yr. CAGR %	12.08	13.63	23.51	17.02	15.2
Net Property, Plant and Equip., 5 Yr. CAGR %	3.04	2.9	11.88	9.42	5.5
Total Assets, 5 Yr. CAGR %	15.13	14.02	14.62	7.02	5.69
Tangible Book Value, 5 Yr. CAGR %	3.63	4.15	4.68	14.68	12.16
Common Equity, 5 Yr. CAGR %	10.48	10.18	10.2	9.11	7.98
Cash From Operations, 5 Yr. CAGR %	20.7	23.58	11.84	4.75	3.74
Capital Expenditures, 5 Yr. CAGR %	-4.26	11.56	-5.63	-4.01	-8.68
Levered Free Cash Flow, 5 Yr. CAGR %	74.18	8	-21.34	15.76	76.38
Unlevered Free Cash Flow, 5 Yr. CAGR %	68.05	9.6	-15.74	12.09	63.6
Dividend Per Share, 5 Yr. CAGR %	11.63	10.29	13.14	10.67	12.41